Cargando…
Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
INTRODUCTION: Recent studies show that spasticity occurs in 20–30% of all stroke victims, especially in younger patients. Botulinum toxin is a very effective treatment; however, it is not reimbursed in the Ukraine, thus leaving patients untreated and unable to use the paralyzed limb. Finally, this m...
Autores principales: | Chemer, Nataliia, Bilanovskyi, Volodymyr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534635/ https://www.ncbi.nlm.nih.gov/pubmed/30778859 http://dx.doi.org/10.1007/s40120-019-0128-1 |
Ejemplares similares
-
Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation
por: Martinez, RM
Publicado: (2017) -
Efficacy and safety of Cerebrolysin in
patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010) -
The Avant Rehabilitation Program and Cerebrolysin for Treatment of Post-Stroke Dysphagia: A Case Report
por: Hien, Nguyen Minh, et al.
Publicado: (2019) -
Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022) -
Role of Cerebrolysin(®) in Rehabilitation in Ischemic Stroke: A Case Report
por: Chanubol, Ratanapat, et al.
Publicado: (2021)